Pascal and Francis Bibliographic Databases


Search results

Your search


Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 256

  • Page / 11

Selection :

  • and

Unexpected flow cytometric results with two small GPIIb/IIIa blockers : Eptifibatide and tirofibanHEZARD, Nathalie; METZ, Damien; TASSAN-MANGINA, Sophie et al.Thrombosis and haemostasis. 2001, Vol 85, Num 3, pp 561-562, issn 0340-6245Article

Optimal duration of Eptifibatide infusion in percutaneous coronary intervention (an ESPRIT Substudy)REBEIZ, Abdallah G; DERY, Jean-Pierre; JOSEPH, Diane et al.The American journal of cardiology. 2004, Vol 94, Num 7, pp 926-929, issn 0002-9149, 4 p.Article

Combined effects of melagatran and eptifibatide on platelet aggregation inhibition but not thrombin generation inhibitionKOESTENBERGER, Martin; GALLISTL, Siegfried; CVIRN, Gerhard et al.Blood coagulation & fibrinolysis. 2004, Vol 15, Num 2, pp 131-137, issn 0957-5235, 7 p.Article

Thrombopénies induites par les antagonistes du complexe GPIIbIIIa plaquettaire administrés par voie injectable = Anti-GPIIbIIIa induced thrombocytopeniaLE BELLER, Christine; ALHENC-GELAS, Martine.Hématologie (Montrouge). 2004, Vol 10, Num 1, pp 14-23, issn 1264-7527, 10 p.Article

Intérêt de l'eptifibatide au cours de l'angioplastie de sauvetage avec stenting coronaire après échec de thrombolyse: À propos d'une série de 41 patients = Significance of eptifibatide during salvage angioplasty with coronary stenting after failure of thrombolysisIDIR, M; DELARCHE, N; BANCS, Jl et al.Archives des maladies du coeur et des vaisseaux. 2002, Vol 95, Num 10, pp 903-907, issn 0003-9683Conference Paper

Eptifibatide overdosePARAKH, Sagun; NAIK, Nimesh; ROHATGI, Nidhi et al.International journal of cardiology. 2009, Vol 131, Num 3, pp 430-432, issn 0167-5273, 3 p.Article

Blockade of GPIIb/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemiaDERHASCHNIG, Ulla; PACHINGER, Christine; SCHWEEGER-EXELI, Ingrid et al.Thrombosis and haemostasis. 2003, Vol 90, Num 6, pp 1054-1060, issn 0340-6245, 7 p.Article

Characterization of eptifibatide during drug formulation stability assaysRONGHUA WANG; FEDER, Debby; HSIEH, Frank et al.Journal of pharmaceutical and biomedical analysis. 2003, Vol 33, Num 5, pp 1181-1187, issn 0731-7085, 7 p.Article

Eptifibatide-associated acute, profound thrombocytopeniaCOONS, James C; BARCELONA, Robert A; FREEDY, Tucker et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 2, pp 368-372, issn 1060-0280, 5 p.Article

Acute profound thrombocytopenbia after use of eptifibatide for coronary stenting. CommentaryBLOCK, Peter C; SALENGRO, Emmanuel; MULVIHILL, Niall T et al.Catheterization and cardiovascular interventions. 2003, Vol 58, Num 1, pp 72-75, issn 1522-1946, 4 p.Article

Thrombocytopenia resulting from sensitivity to GPIIb-IIIa inhibitorsASTER, Richard H; CURTIS, Brian R; BOUGIE, Daniel W et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 5, pp 569-577, issn 0094-6176, 9 p.Article

A novel method to assess platelet inhibition by eptifibatide with Thrombelastograph®KATORI, Nobuyuki; SZLAM, Fania; LEVY, Jerrold H et al.Anesthesia and analgesia. 2004, Vol 99, Num 6, pp 1794-1799, issn 0003-2999, 6 p.Article

Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofibanMARCINIAK, Stanley J; JORDAN, Robert E; MASCELLI, Mary A et al.Thrombosis and haemostasis. 2001, Vol 85, Num 3, pp 539-543, issn 0340-6245Article

In vitro dose response to different GPIIb/IIIa-antagonists : Inter-laboratory comparison of various platelet function testsHARDER, S; KLINKHARDT, U; BREDDIN, H. K et al.Thrombosis research. 2001, Vol 102, Num 1, pp 39-48, issn 0049-3848Article

Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjectsHOLMES, M. B; SOBEL, B. E; SCHNEIDER, D. J et al.The American journal of cardiology. 1999, Vol 84, Num 2, pp 203-207, issn 0002-9149Article

Association of Eptifibatide and acute profound thrombocytopeniaHONGO, Richard H; BRENT, Bruce N.The American journal of cardiology. 2001, Vol 88, Num 4, pp 428-431, issn 0002-9149Article

Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromesGREENBAUM, Adam B; HARRINGTON, Robert A; LINCOFF, A. Michael et al.Journal of the American College of Cardiology. 2001, Vol 37, Num 2, pp 492-498, issn 0735-1097Article

Glycoprotein IIb/IIIa receptor inhibitors in percutaneous coronary intervention and acute coronary syndromeCROUCH, Michael A; NAPPI, Jean M; CHEANG, Kai I et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 860-875, issn 1060-0280, 16 p.Article

Assessment of Eptifibatide Clearance by Hemodialysis Using an in vitro SystemHUDSON, Joanna Q; MCNEELY, Elizabeth B; GREEN, Christie A et al.Blood purification. 2010, Vol 30, Num 4, pp 266-271, issn 0253-5068, 6 p.Article

Évaluation de l'utilisation d'un inhibiteur de la glycoprotéine IIbIIIa, l'integrilin®, dans un service de cardiologie = Evaluation of a glycoprotein iibiiia receptor inhibitor (Integrilin®) in a cardiology unitWOLFF, E; PISANTE, L; MICHAUD, P et al.Journal de pharmacie clinique (Paris). 2003, Vol 22, Num 2, pp 64-68, issn 0291-1981, 5 p.Article

Low incidence of paradoxical platelet activation by glycoprotein IIb/IIIa inhibitorsWEBER, Artur-Aron; MEILA, Dan; JACOBS, Collin et al.Thrombosis research. 2002, Vol 106, Num 1, pp 25-29, issn 0049-3848Article

Regulation of CD40L (CD154) and CD62P (p-selectin) Surface Expression upon GPIIb-IIIa Blockade of Platelets from Stable Coronary Artery Disease PatientsBLEAKLEY CHANDLER, A; EARHART, Angela D; SPEICH, Henry E et al.Thrombosis research. 2010, Vol 125, Num 1, pp 44-52, issn 0049-3848, 9 p.Article

Prolonged intravenous eptifibatide infusion for prevention of coronary stent thrombosisJAFFE, Ronen; HALON, David A; CARMELI, Judith et al.International journal of cardiology. 2007, Vol 114, Num 3, pp 409-411, issn 0167-5273, 3 p.Article

Long-Term Results Following Switch From Abciximab to Eptifibatide During Percutaneous Coronary InterventionKOUTOUZIS, Michael; LAGERQVIST, Bo; OLDGREN, Jonas et al.Clinical cardiology (Mahwah, NJ). 2010, Vol 33, Num 11, pp 686-692, issn 0160-9289, 7 p.Article

Abbreviated Infusion of Eptifibatide After Successful Coronary Intervention : The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) Randomized TrialFUNG, Anthony Y; SAW, Jacqueline; WEBB, John G et al.Journal of the American College of Cardiology. 2009, Vol 53, Num 10, pp 837-845, issn 0735-1097, 9 p.Article

  • Page / 11